Esika - 13537-355-02 - (OCTINOXATE and TITANIUM DIOXIDE)

Alphabetical Index


Drug Information of Esika

Product NDC: 13537-355
Proprietary Name: Esika
Non Proprietary Name: OCTINOXATE and TITANIUM DIOXIDE
Active Ingredient(s): .02; .044    g/g; g/g & nbsp;   OCTINOXATE and TITANIUM DIOXIDE
Administration Route(s): TOPICAL
Dosage Form(s): POWDER
Coding System: National Drug Codes(NDC)

Labeler Information of Esika

Product NDC: 13537-355
Labeler Name: Ventura Corporation (San Juan, P.R)
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20110724

Package Information of Esika

Package NDC: 13537-355-02
Package Description: 1 JAR in 1 BOX (13537-355-02) > 15 g in 1 JAR (13537-355-01)

NDC Information of Esika

NDC Code 13537-355-02
Proprietary Name Esika
Package Description 1 JAR in 1 BOX (13537-355-02) > 15 g in 1 JAR (13537-355-01)
Product NDC 13537-355
Product Type Name HUMAN OTC DRUG
Non Proprietary Name OCTINOXATE and TITANIUM DIOXIDE
Dosage Form Name POWDER
Route Name TOPICAL
Start Marketing Date 20110724
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura Corporation (San Juan, P.R)
Substance Name OCTINOXATE; TITANIUM DIOXIDE
Strength Number .02; .044
Strength Unit g/g; g/g
Pharmaceutical Classes

Complete Information of Esika


General Information